Promising phase 1 trial results: Use of sotorasib (AMG 510) in patients with solid tumors
A phase 1 clinical trial of sotorasib (AMG 510) in patients with heavily pretreated advanced solid tumors shows encouraging anti-cancer activity, especially in lung and colorectal cancers, reports a new study led by City ...
Sep 21, 2020
0
3